Hims & Hers said its oral semaglutide "empowers providers to tailor treatment plans specifically for those who prefer to avoid needles or need smaller doses to help to balance side-effects." It added that its compounding operations "adhere to all federal and state standards for compounding, and all active pharmaceutical ingredientsin compounded treatments are sourced exclusively from FDA-registered facilities." In its statement, Novo Nordisk said the American Diabetes Association's Obesity Association recently published new standards of care, which "discourage the use of compounded GLP-1s due to safety, quality, and effectiveness concerns." Meanwhile, FDA Commissioner Marty Makary delivered some encouraging news to Novo Nordisk, after pledging "swift action against companies mass-marketing illegal copycat drugs, claiming they are similar to FDA-approved products."
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
Study cohorts We designed five active-comparator, new-user cohort studies including patients with obesity and type 2 diabetes at elevated cardiovascular risk 46
'When you compare my blood glucose management to an 18-year-old, I'm better than 99 out of 100.' He balances this success with the potential side effects of taking a GLP-1, which affects certain biomarkers that Johnson measures obsessively, including his resting heart rate
People don't realize like they get a DEXA and they're like, oh, that's my body fat
The bill also allows the Secretary to increase the $15,000 base fee you pay to the FDA
Oral GLP-1s, such as Wegovy (semaglutide) pills, are effective but require careful timing and consistency to work properly